Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Biomarker panels associated with progression of renal disease in type 1 diabetes.

Colombo M, Valo E, McGurnaghan SJ, Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue PM, Forsblom C, Colhoun HM; FinnDiane Study Group and the Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Collaboration.

Diabetologia. 2019 Sep;62(9):1616-1627. doi: 10.1007/s00125-019-4915-0. Epub 2019 Jun 20.

2.

Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes.

Syreeni A, Sandholm N, Cao J, Toppila I, Maahs DM, Rewers MJ, Snell-Bergeon JK, Costacou T, Orchard TJ, Caramori ML, Mauer M, Klein BEK, Klein R, Valo E, Parkkonen M, Forsblom C, Harjutsalo V, Paterson AD; DCCT/EDIC Research Group, Groop PH; FinnDiane Study Group.

Diabetes. 2019 Apr;68(4):858-867. doi: 10.2337/db18-0573. Epub 2019 Jan 23.

PMID:
30674623
3.

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS.

Diabetes Care. 2019 Jan;42(1):93-101. doi: 10.2337/dc18-1369. Epub 2018 Nov 19.

PMID:
30455333
4.

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes.

Sandholm N, Haukka JK, Toppila I, Valo E, Harjutsalo V, Forsblom C, Groop PH.

Sci Rep. 2018 Aug 17;8(1):12408. doi: 10.1038/s41598-018-29211-1.

5.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

6.

The Genetic Landscape of Renal Complications in Type 1 Diabetes.

Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Trégouët D, Dahlström E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M; The FinnDiane Study Group, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD; The DCCT/EDIC Study Group, Florez JC, Hirschhorn JN, Maxwell AP; GENIE Consortium, Dunger D, Cobelli C, Colhoun HM, Groop L, McCarthy MI, Groop PH; SUMMIT Consortium.

J Am Soc Nephrol. 2017 Feb;28(2):557-574. doi: 10.1681/ASN.2016020231. Epub 2016 Sep 19.

7.

Early Trichinella spiralis and Trichinella nativa infections induce similar gene expression profiles in rat jejunal mucosa.

Airas N, Näreaho A, Lindén J, Valo E, Hautaniemi S, Jokelainen P, Sukura A.

Exp Parasitol. 2013 Oct;135(2):363-9. doi: 10.1016/j.exppara.2013.07.024. Epub 2013 Aug 8.

PMID:
23932900
8.

ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.

Rafn B, Nielsen CF, Andersen SH, Szyniarowski P, Corcelle-Termeau E, Valo E, Fehrenbacher N, Olsen CJ, Daugaard M, Egebjerg C, Bøttzauw T, Kohonen P, Nylandsted J, Hautaniemi S, Moreira J, Jäättelä M, Kallunki T.

Mol Cell. 2012 Mar 30;45(6):764-76. doi: 10.1016/j.molcel.2012.01.029.

9.

Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.

Mathiasen DP, Egebjerg C, Andersen SH, Rafn B, Puustinen P, Khanna A, Daugaard M, Valo E, Tuomela S, Bøttzauw T, Nielsen CF, Willumsen BM, Hautaniemi S, Lahesmaa R, Westermarck J, Jäättelä M, Kallunki T.

Oncogene. 2012 Jan 19;31(3):390-401. doi: 10.1038/onc.2011.230. Epub 2011 Jun 27.

PMID:
21706057
10.

Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma.

Koivula S, Valo E, Raunio A, Hautaniemi S, Leppä S.

Oncol Rep. 2011 Apr;25(4):1183-90. doi: 10.3892/or.2011.1179. Epub 2011 Feb 10.

PMID:
21318224
11.

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme.

Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomäki V, Valo E, Núñez-Fontarnau J, Rantanen V, Karinen S, Nousiainen K, Lahesmaa-Korpinen AM, Miettinen M, Saarinen L, Kohonen P, Wu J, Westermarck J, Hautaniemi S.

Genome Med. 2010 Sep 7;2(9):65. doi: 10.1186/gm186.

12.

Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.

Taskinen M, Valo E, Karjalainen-Lindsberg ML, Hautaniemi S, Meri S, Leppä S.

Clin Cancer Res. 2010 May 1;16(9):2615-23. doi: 10.1158/1078-0432.CCR-09-3269. Epub 2010 Apr 13.

13.

Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.

Backlund M, Paukku K, Daviet L, De Boer RA, Valo E, Hautaniemi S, Kalkkinen N, Ehsan A, Kontula KK, Lehtonen JY.

Nucleic Acids Res. 2009 Apr;37(7):2346-58. doi: 10.1093/nar/gkp098. Epub 2009 Feb 26.

14.

The effect of sevoflurane on glutamate release and uptake in rat cerebrocortical presynaptic terminals.

Vinje ML, Moe MC, Valø ET, Berg-Johnsen J.

Acta Anaesthesiol Scand. 2002 Jan;46(1):103-8.

PMID:
11903082
15.

Moderate hypothermia blunts the inflammatory response and reduces organ injury after acute haemorrhage.

Gundersen Y, Vaagenes P, Pharo A, Valø ET, Opstad PK.

Acta Anaesthesiol Scand. 2001 Sep;45(8):994-1001.

PMID:
11576051
16.

Measured increase in intracellular Ca(2+) during stimulated release of endogenous glutamate from human cerebrocortical synaptosomes.

Vinje ML, Valø ET, Røste GK, Berg-Johnsen J.

Brain Res. 1999 Oct 2;843(1-2):199-201.

PMID:
10528126
17.

Isoflurane reduces synaptic glutamate release without changing cytosolic free calcium in isolated nerve terminals.

Larsen M, Valø ET, Berg-Johnsen J, Langmoen IA.

Eur J Anaesthesiol. 1998 Mar;15(2):224-9.

PMID:
9587730
18.

Changes in brain amino acid content induced by hyposmolar stress and energy deprivation.

Haugstad TS, Valø ET, Langmoen IA.

Neurol Res. 1995 Dec;17(6):402-8.

PMID:
8622791
19.

RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.

Pettersen RD, Hestdal K, Lee N, Geraghty DE, Valø ET, Lie SO, Gaudernack G.

Tissue Antigens. 1995 Mar;45(3):203-12.

PMID:
7539160

Supplemental Content

Support Center